Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1995-04-14
1997-06-10
Rollins, John W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 23, 514 53, 514 54, 514 62, 514885, 514934, 4241951, 530370, 530379, A61K 3800, A61K 3170, A61K 31715, A61K 3578
Patent
active
056375638
ABSTRACT:
A method for making and identifying mistletoe extracts as being of a pharmaceutical grade which is useful in treating AIDS, cancers and other diseases where the immune system is suppressed. The method is based on the discovery of five marker proteins which selectively bind with different sugars. Pharmaceutical grade extracts in accordance with the invention require certain concentration levels of each protein. An additional further requirement is that each protein fraction must meet specific bioactivity levels with respect to preventing malignant cell proliferation. Fingerprint markers with respect to viscotoxins and alkaloids present in the extract are also provided. Methods of treatment using the pharmaceutical grade mistletoe are disclosed.
REFERENCES:
patent: 3394120 (1968-07-01), Vester
patent: 3472831 (1969-10-01), Vester
patent: 3475402 (1969-10-01), Vester
patent: 4525344 (1985-06-01), Tutsky
patent: 4590071 (1986-05-01), Scannon et al.
patent: 4784849 (1988-11-01), Tutsky
patent: 4861581 (1989-08-01), Epstein et al.
patent: 4894443 (1990-01-01), Greenfield et al.
patent: 4966577 (1990-10-01), Crosson et al.
patent: 5019368 (1991-05-01), Epstein et al.
patent: 5093475 (1992-03-01), Carroll et al.
patent: 5183904 (1993-02-01), Carroll et al.
S. Krager AG, "Cancer of the Exocrine Pancreas," Oncology, vol. 12, pp. 1-70, 1986.
Gabius et al., "Cytokines as Mediators in Rationally Standardized Mistletoe Therapy," Abstracts of the Third International Conference of Anticancer Research, 16-20 Oct. 1990, Marathon, Greece, No. 385, pp. 1473-1474.
Rentea et al., "Biologic Properties of Iscador: A Viscum album Preparation," Laboratory Investigation, Vo. 44, No. 1, pp. 43-48, 1981.
Ribereau-Gayon et al., "Effects of mistletoe (Viscum album L.) extracts on cultured tumor cells," Experientia 42, pp. 594-599 (1986).
Gabius et al., "The immunomodulatory .beta.-Galactoside-Specific Lectin from Mistletoe: Partial Sequence Analysis, Cell and Tissue Binding, and Impact on Intracellular Biosignalling of Monocytic Leukemia Cells," Anticancer Research 12:669-676 (1992).
Kayser et al., "Analysis of tumour necrosis factor .alpha.-specific, lactose-specific and mistletoe lectin-specific binding sites in human lung carcinomas by labelled ligands," Virchows Archiv A Pathol Anat (1992) 421:345-349.
Gabius et al., "The galactoside-specific lectin from mistletoe as biological response modifier," Int'l Journal of Oncology, 1, 705-708, 1992.
Hajto, "Modulatory Potency of the .beta.-Galactoside-specific Lectin from Mistletoe Extract (Iscador) on the Host Defense System in Vivo in Rabbits and Patients," Cancer Research, 49, 4803-4808, 1991.
Beuth et al., "Behavior of lymphocyte subsets and expression of activation markers in response to immunotherapy with galactoside-specific lectin from mistletoe in breast cancer patients," Clin. Investig. (1992) 70:658-661.
Bloksma, "Simulation of Humoral and Cellular Immunity by Viscum Preparations," pp. 2-8.
Khwaja et al., "Experimental Basis for the Use of `Iscador` in Cancer Treatment," 13th International Congress of Chemotherapy, Vienna 28th Aug. to 2nd Sep. 1983.
Khwaja et al., "Isolation of biologically active alkaloids from Korean mistletoe Viscum album, coloratum," Experientia 36 (1980).
Khwaja et al., "Studies on Cytotoxic and Immunologic Effects of Viscum album (Mistletoe)," AACR 22, 253, 1981.
Khwaja et al., "Isolation of Cytotoxic Proteins from Viscum album, coloratum," AACR Abstract Form, 1985.
Khwaja et al., "Isolation of Cytotoxic Lectin from Viscum album, Coloratum," Proceedings of AACR, vol. 28, Mar. 1987, p. 303.
Khwaja et al., "Characterization of Biologically Active Components of Viscum album (Mistletoe)," Poster Abstract Form for publication in the Journal of Cancer Research Clinical Oncology, 1989.
Khwaja et al., "Characterization of cytotoxic lectins isolated from Viscum album, Coloratum," AACR, vol. 30, p. 576, 1989.
Khwaja et al., "Characterization of biologically active components of Mistletoe," AACR, 1990.
Khwaja et al., "Biopharmacological Studies of Different Components of Viscum album (Mistletoe)," Abstracts of the Third International Conference of Anticancer Research, pp. 1374-1375, 1990.
Rollins John W.
University of Southern California
LandOfFree
Mistletoe extract and method does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Mistletoe extract and method, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mistletoe extract and method will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-764595